The Connecting Patient Populations to Clinical Trials (CP2CT) program will implement and evaluate multilevel and tailored outreach and education interventions with the primary goal of increasing referral and ultimately, accrual of patient populations, to NCI-supported clinical trials (CTs) (National Clinical Trial Network (NCTN), NCI's Community Oncology Research Program (NCORP), and Experimental Therapeutics Clinical Trials Network (ETCTN). These programs’ will address cancer health disparities through a network of local multidisciplinary and integrated partners.
Without representative populations, especially in therapeutic trials, cancer disparities are likely to increase as all people may not be able to fully benefit from cutting-edge treatments and the promises of precision medicine.
If you have any questions about the program, please email CP2CT@mail.nih.gov.